Y-Intercept »

Humacyte shares owned by Y-Intercept

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $68k 88k 0.78
2023-03-31 $45k 15k 3.09
2022-03-31 $121k 17k 7.07

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding Humacyte

Vanguard Capital Management
Antipodes Partners
Alyeska Investment Group
Davidson Kempner Capital Management
BlackRock
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Susquehanna International
UBS Group
AQR Capital Management
Geode Capital Management
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Humacyte